Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration

Int J Hematol. 2018 Jun;107(6):717-719. doi: 10.1007/s12185-018-2456-9. Epub 2018 Apr 18.

¹ Hematology/Oncology, Wakayama Medical University, Kimiidera 811-1, Wakayama, 641-8510, Japan.
² Department of Cell Therapy, Institute of Biomedical Research and Innovation, 2-2, Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
³ Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasakicho, Tennoji-ku, Osaka, 543-8555, Japan.
⁴ Department of General Medicine, National Hospital Organization, Kumamoto Minami Hospital, Kumamoto, Japan.
⁵ Division of Advanced Biomedical Engineering Research, Center for Stem Cell and Regenerative Medicine, Institute of Research, Tokyo Medical and Dental University, Tokyo, Japan.
⁶ Hematology/Oncology, Wakayama Medical University, Kimiidera 811-1, Wakayama, 641-8510, Japan. [email protected].

No abstract available

Publication types